arpp19 Search Results


90
Sino Biological recombinant gst arpp19
Recombinant Gst Arpp19, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant gst arpp19/product/Sino Biological
Average 90 stars, based on 1 article reviews
recombinant gst arpp19 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc ensa
Mast2 (294–1197) robustly phosphorylates <t>S67-ENSA.</t> A, the site-specific information of selected significantly upregulated peptides from B ( green box ). B, nonradiolabeled substrate assay of ENSA (MCE) phosphorylated by Mast2 (294–1197). Total ENSA and FLAG immunoblot are shown with a <t>representative</t> <t>pS67-ENSA</t> blot ( right ), and phosphorylation was quantified by percent maximal AU with each aligned data point shown over a nonlinear curve determination ( left ). K m was calculated using GraphPad Prism. MAST, microtubule-associated serine/threonine; ENSA, endosulfine-α.
Ensa, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ensa/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
ensa - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
Proteintech arpp19
RT‐qPCR showing the mRNA expression of (A) ZNF207 , (B) ZNRF1 , (C) RGS1 , (D) <t>ARPP19</t> , (E) CXCR4 , and (F) CTLA4 in paracancerous (principal component, PC) tissues ( n = 10) and gastric cancer (GC) samples ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001.
Arpp19, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arpp19/product/Proteintech
Average 94 stars, based on 1 article reviews
arpp19 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
Proteintech arpp 19
RT‐qPCR showing the mRNA expression of (A) ZNF207 , (B) ZNRF1 , (C) RGS1 , (D) <t>ARPP19</t> , (E) CXCR4 , and (F) CTLA4 in paracancerous (principal component, PC) tissues ( n = 10) and gastric cancer (GC) samples ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001.
Arpp 19, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arpp 19/product/Proteintech
Average 92 stars, based on 1 article reviews
arpp 19 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

91
Boster Bio calnexin
RT‐qPCR showing the mRNA expression of (A) ZNF207 , (B) ZNRF1 , (C) RGS1 , (D) <t>ARPP19</t> , (E) CXCR4 , and (F) CTLA4 in paracancerous (principal component, PC) tissues ( n = 10) and gastric cancer (GC) samples ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001.
Calnexin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/calnexin/product/Boster Bio
Average 91 stars, based on 1 article reviews
calnexin - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp arpp19 hs01055630 g1
RT‐qPCR showing the mRNA expression of (A) ZNF207 , (B) ZNRF1 , (C) RGS1 , (D) <t>ARPP19</t> , (E) CXCR4 , and (F) CTLA4 in paracancerous (principal component, PC) tissues ( n = 10) and gastric cancer (GC) samples ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001.
Gene Exp Arpp19 Hs01055630 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp arpp19 hs01055630 g1/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
gene exp arpp19 hs01055630 g1 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology arpp19 #mbs9609642 antibody
AKT pathway signaling is suppressed by sh-IGFL2-AS1. ( A ) Schematic depicting the IGFL2-AS1 pathway. ( B ) Relative transcription of <t>ARPP19,</t> measured using qRT PCR. The graph depicts the levels of ARPP19 in the indicated cell lines. Data are normalized to those of the sh-NC-HT29 cell line; error bars indicate SDs. *** p < 0.001. ( C ) Protein expression of ARPP19, measured by western blotting. The expression of β-actin was used as a loading control. ( D ) Western blot analyses of various proteins downstream of AKT. Cells incubated as indicated after irradiation (3 Gy) were lysed and analyzed by western blotting; β-actin was used as a loading control. ( E – H ) Densitometric measurements of protein expressions, corresponding to ( D ). The results are presented as the ratio of phosphor-AKT/AKT ( E ), cyclin D1/β-actin ( F ), c-Myc/β-actin ( G ), and E-cadherin/β-actin ( H ).
Arpp19 #Mbs9609642 Antibody, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arpp19 #mbs9609642 antibody/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
arpp19 #mbs9609642 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma si-arpp19
AKT pathway signaling is suppressed by sh-IGFL2-AS1. ( A ) Schematic depicting the IGFL2-AS1 pathway. ( B ) Relative transcription of <t>ARPP19,</t> measured using qRT PCR. The graph depicts the levels of ARPP19 in the indicated cell lines. Data are normalized to those of the sh-NC-HT29 cell line; error bars indicate SDs. *** p < 0.001. ( C ) Protein expression of ARPP19, measured by western blotting. The expression of β-actin was used as a loading control. ( D ) Western blot analyses of various proteins downstream of AKT. Cells incubated as indicated after irradiation (3 Gy) were lysed and analyzed by western blotting; β-actin was used as a loading control. ( E – H ) Densitometric measurements of protein expressions, corresponding to ( D ). The results are presented as the ratio of phosphor-AKT/AKT ( E ), cyclin D1/β-actin ( F ), c-Myc/β-actin ( G ), and E-cadherin/β-actin ( H ).
Si Arpp19, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/si-arpp19/product/Shanghai GenePharma
Average 90 stars, based on 1 article reviews
si-arpp19 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier



N/A
Transient overexpression of ARPP19 NM 006628 in HEK293T cells paraffin embedded 4 um sections controls for ICC IHC staining 25 slides per pack
  Buy from Supplier

N/A
Lenti ORF particles Arpp19 Myc DDK tagged ORF Rat cyclic AMP phosphoprotein Arpp 19 200ul 10 7 TU mL
  Buy from Supplier

Image Search Results


Mast2 (294–1197) robustly phosphorylates S67-ENSA. A, the site-specific information of selected significantly upregulated peptides from B ( green box ). B, nonradiolabeled substrate assay of ENSA (MCE) phosphorylated by Mast2 (294–1197). Total ENSA and FLAG immunoblot are shown with a representative pS67-ENSA blot ( right ), and phosphorylation was quantified by percent maximal AU with each aligned data point shown over a nonlinear curve determination ( left ). K m was calculated using GraphPad Prism. MAST, microtubule-associated serine/threonine; ENSA, endosulfine-α.

Journal: The Journal of Biological Chemistry

Article Title: Characterization of Mast2 kinase defines structural features, regulation, and substrates

doi: 10.1016/j.jbc.2025.110922

Figure Lengend Snippet: Mast2 (294–1197) robustly phosphorylates S67-ENSA. A, the site-specific information of selected significantly upregulated peptides from B ( green box ). B, nonradiolabeled substrate assay of ENSA (MCE) phosphorylated by Mast2 (294–1197). Total ENSA and FLAG immunoblot are shown with a representative pS67-ENSA blot ( right ), and phosphorylation was quantified by percent maximal AU with each aligned data point shown over a nonlinear curve determination ( left ). K m was calculated using GraphPad Prism. MAST, microtubule-associated serine/threonine; ENSA, endosulfine-α.

Article Snippet: Primary antibodies for total AKT (2920S), phospho-specific AKT (pT308, 9275S and pS473, 4060L), phospho-specific S6K (pT389, 9205S), phospho-specific ENSA (pS67, 5240S), and total ENSA (8770S) were from Cell Signaling.

Techniques: Western Blot, Phospho-proteomics

RT‐qPCR showing the mRNA expression of (A) ZNF207 , (B) ZNRF1 , (C) RGS1 , (D) ARPP19 , (E) CXCR4 , and (F) CTLA4 in paracancerous (principal component, PC) tissues ( n = 10) and gastric cancer (GC) samples ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Quantitative Biology

Article Title: Metabolic‐immune interactions in gastric cancer T cells: A single‐cell atlas for prognostic biomarker identification

doi: 10.1002/qub2.70027

Figure Lengend Snippet: RT‐qPCR showing the mRNA expression of (A) ZNF207 , (B) ZNRF1 , (C) RGS1 , (D) ARPP19 , (E) CXCR4 , and (F) CTLA4 in paracancerous (principal component, PC) tissues ( n = 10) and gastric cancer (GC) samples ( n = 10). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Immunohistochemical staining was then carried out using primary antibodies targeting RGS1 (Sigma, HPA028453), CXCR4 (Cell Signaling Technology, #97680), CTLA4 (Cell Signaling Technology, #53560), ARPP19 (Proteintech, 11678‐1‐AP), ZNRF1 (LSBio, LS‐C809970), and ZNF207 (Invitrogen, PA5‐53535).

Techniques: Quantitative RT-PCR, Expressing

Immunohistochemical staining of target genes (A) ZNF207 , (B) ARPP19 , (C) ZNRF1 , (D) CXCR4 , (E) RGS1 , and (F) CTLA4 expression profiles in gastric cancer specimens and their corresponding adjacent normal gastric tissues. Brown chromogenic staining reveals positive protein expression. Blue counterstaining visualizes cell nuclei. Scale bar: 100 μm.

Journal: Quantitative Biology

Article Title: Metabolic‐immune interactions in gastric cancer T cells: A single‐cell atlas for prognostic biomarker identification

doi: 10.1002/qub2.70027

Figure Lengend Snippet: Immunohistochemical staining of target genes (A) ZNF207 , (B) ARPP19 , (C) ZNRF1 , (D) CXCR4 , (E) RGS1 , and (F) CTLA4 expression profiles in gastric cancer specimens and their corresponding adjacent normal gastric tissues. Brown chromogenic staining reveals positive protein expression. Blue counterstaining visualizes cell nuclei. Scale bar: 100 μm.

Article Snippet: Immunohistochemical staining was then carried out using primary antibodies targeting RGS1 (Sigma, HPA028453), CXCR4 (Cell Signaling Technology, #97680), CTLA4 (Cell Signaling Technology, #53560), ARPP19 (Proteintech, 11678‐1‐AP), ZNRF1 (LSBio, LS‐C809970), and ZNF207 (Invitrogen, PA5‐53535).

Techniques: Immunohistochemical staining, Staining, Expressing

AKT pathway signaling is suppressed by sh-IGFL2-AS1. ( A ) Schematic depicting the IGFL2-AS1 pathway. ( B ) Relative transcription of ARPP19, measured using qRT PCR. The graph depicts the levels of ARPP19 in the indicated cell lines. Data are normalized to those of the sh-NC-HT29 cell line; error bars indicate SDs. *** p < 0.001. ( C ) Protein expression of ARPP19, measured by western blotting. The expression of β-actin was used as a loading control. ( D ) Western blot analyses of various proteins downstream of AKT. Cells incubated as indicated after irradiation (3 Gy) were lysed and analyzed by western blotting; β-actin was used as a loading control. ( E – H ) Densitometric measurements of protein expressions, corresponding to ( D ). The results are presented as the ratio of phosphor-AKT/AKT ( E ), cyclin D1/β-actin ( F ), c-Myc/β-actin ( G ), and E-cadherin/β-actin ( H ).

Journal: International Journal of Molecular Sciences

Article Title: IGFL2-AS1, a Long Non-Coding RNA, Is Associated with Radioresistance in Colorectal Cancer

doi: 10.3390/ijms24020978

Figure Lengend Snippet: AKT pathway signaling is suppressed by sh-IGFL2-AS1. ( A ) Schematic depicting the IGFL2-AS1 pathway. ( B ) Relative transcription of ARPP19, measured using qRT PCR. The graph depicts the levels of ARPP19 in the indicated cell lines. Data are normalized to those of the sh-NC-HT29 cell line; error bars indicate SDs. *** p < 0.001. ( C ) Protein expression of ARPP19, measured by western blotting. The expression of β-actin was used as a loading control. ( D ) Western blot analyses of various proteins downstream of AKT. Cells incubated as indicated after irradiation (3 Gy) were lysed and analyzed by western blotting; β-actin was used as a loading control. ( E – H ) Densitometric measurements of protein expressions, corresponding to ( D ). The results are presented as the ratio of phosphor-AKT/AKT ( E ), cyclin D1/β-actin ( F ), c-Myc/β-actin ( G ), and E-cadherin/β-actin ( H ).

Article Snippet: Primary antibodies against ARPP19 (#MBS9609642) were obtained from MyBioSource (San Diego, CA, USA); phospho-AKT (#4060) and AKT (#4691) were obtained from Cell Signaling Technology; c-Myc (#sc-764), cyclin D1 (#sc-753), E-cadherin (#sc-8426), and β-actin (#sc-47778) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

Techniques: Quantitative RT-PCR, Expressing, Western Blot, Control, Incubation, Irradiation